Health
EBMT trial shows improvements in treatment of Severe Aplastic Anaemia – Science Codex
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting. Preliminary data show that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with Severe Aplastic Anaemia (SAA).
SAA is a condition in which the bone m…
-
Noosa News24 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
General15 hours agoFrench far-right supporters rally against Le Pen conviction in Paris
-
General22 hours agoFire razes Tumby Bay hardware store with damage likely to exceed $1m